Teva Pharmaceutical Industries Limited
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2007 | $9.41B | $2.40B | $1.91B |
| FY2008 | $11.09B | $1.15B | $609.0M |
| FY2009 | $16.12B | $2.41B | $2.00B |
| FY2010 | $16.12B | $3.87B | $3.33B |
| FY2011 | $18.31B | $3.11B | $2.76B |
| FY2012 | $20.32B | $2.21B | $1.96B |
| FY2013 | $20.31B | $1.65B | $1.27B |
| FY2014 | $20.27B | $3.95B | $3.06B |
| FY2015 | $19.65B | $3.35B | $1.59B |
| FY2016 | $21.90B | $2.15B | $329.0M |
| FY2017 | $21.85B | $-17.48B | $-16.27B |
| FY2018 | $18.27B | $-1.64B | $-2.15B |
| FY2019 | $16.89B | $-443.0M | $-999.0M |
| FY2020 | $16.66B | $-3.57B | $-3.99B |
| FY2021 | $15.88B | $1.72B | $417.0M |
| FY2022 | $14.93B | $-2.20B | $-2.45B |
| FY2023 | $15.85B | $433.0M | $-559.0M |
| FY2024 | $16.54B | $-303.0M | $-1.64B |
| FY2025 | $17.26B | $2.16B | $1.41B |